Kwak Y, Jeong J, Lee S, Park YU, Lee SA, Han DH, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Ferrari F., Moretti A., Villa R.F
Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA
It has numerous benefits, including better patient compliance, bypassing the first pass effect, ensuring controlled rate of drug release, and allows to swiftly halt or terminating the treatment, if required
The NASM evidence-based review points out that in previous studies, participants who stopped taking GLP-1 medication regained approximately two-thirds of lost weight within a year
Riluzole remains the main approved therapy for ALS, despite yielding only modest survival gains through partial attenuation of glutamatergic excitotoxicity [7073]